Novel pyrogen tests based on the human fever reaction

ATLA Alternatives to Laboratory Animals

Volumn 29, Issue 2, 2001, Pages 99-123

  Hartung, Thomas ^a,f   Aaberge, Ingeborg ^b   Berthold, Susanne ^c   Carlin, Gunnar ^d   Charton, Emmanuelle ^e   Coecke, Sandra ^f   Fennrich, Stefan ^a   Fischer, Matthias ^g   Gommer, Martin ^h   Halder, Marlies ^f   Haslov, Kaare ⁱ   Jahnke, Michael ^j   Montag Lessing, Thomas ^g   Poole, Stephen ^k   Schechtman, Leonard ^l   Wendel, Albrecht ^a   Werner Felmayer, Gabriele ^m  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c Milenia Biotec GmbH   (Germany)

^d MEDICAL PRODUCTS AGENCY   (Sweden)

^e European Network of National Information Centers   (France)

^f JOINT RESEARCH CENTRE   (Italy)

^g PAUL EHRLICH INSTITUT   (Germany)

^h NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

ⁱ STATENS SERUM INSTITUT   (Denmark)

^j Hameln rds GmbH   (Germany)

^k NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^l CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^m UNIVERSITY OF INNSBRUCK   (Austria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; ALUMINUM HYDROXIDE; CYTOTOXIC AGENT; ECHINACIN; ENDOTOXIN; GENTAMICIN; GROWTH HORMONE; HEPATITIS B VACCINE; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN; INFLUENZA VACCINE; PERTUSSIS VACCINE; PYROGEN; RECOMBINANT PROTEIN; TICK BORNE ENCEPHALITIS VACCINE;

ASSAY; CONFERENCE PAPER; DEVICE; DRUG CONTAMINATION; DRUG STERILITY; FEVER; HUMAN; HUMAN EXPERIMENT; INSTRUMENT STERILIZATION; NORMAL HUMAN; PRIORITY JOURNAL; RABBIT;

ACARI; ORYCTOLAGUS CUNICULUS;

EID: 0034996349     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290102900203     Document Type: Conference Paper

References (190)

1. ECVAM (1994). ECVAM News & Views. ATLA 22, 7-11.
2. Dinarello, C.A. (1996). Thermoregulation and the pathogenesis of fever. Infectious Disease Clinics of North America 10, 433-499.
3. Alheim, K. & Bartfai, T. (1998). The interleukin-1 system: receptors, ligands, and ICE in the brain and their involvement in the fever response. Annals of the New York Academy of Sciences 840, 51-58.
4. Galanos, C. & Rietschel, E.T. (1986). Bacterial endotoxins. Infection 14, 155.
5. Freudenberg, M.A. & Galanos, C. (1990). Bacterial lipopolysaccharides: structure, metabolism and mechanisms of action. International Reviews of Immunology 6, 207-221.
6. Holst, O., Ulmer, A.J., Brade, H., Flad, H.D. & Rietschel, E.T. (1996). Biochemistry and cell biology of bacterial endotoxins. FEMS Immunology and Medical Microbiology 16, 83-104.
7. Rietschel, E.T., Brade, L., Holst, O., Kulshin, V.A., Lindner, B., Moran, A.P., Schade, U.F., Zähringer, U. & Brade, H. (1990). Molecular structure of bacterial endotoxin in relation to bioactivity. In Cellular and Molecular Aspects of Endotoxin Reactions (ed. A. Nowotny, J.J. Spitzer & E. J. Ziegler), pp. 15-32. Amsterdam, The Netherlands, Elsevier.
8. Rietschel, E.T., Kirikae, T., Schade, U.F., Mamat, U., Schmidt, G., Loppnow, H., Ulmer, A.J., Zähringer, U., Seydel, U. & Di Padova, F. (1994). Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB Journal 8, 217-225.
9. Rietschel, E.T., Brade, H., Holst, O., Brade, L., Muller-Loennies, S., Mamat, U., Zähringer, U., Beckmann, F., Seydel, U., Brandenburg, K., Ulmer, A.J., Mattern, T., Heine, H., Schletter, J., Loppnow, H., Schonbeck, U., Flad, H.D., Hauschildt, S., Schade, U.F., Di Padova, F., Kusumoto, S. & Schumann, R.R. (1996). Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Current Topics in Microbiology and Immunology 216, 39-81.
10. Derijk, R.H., Strijbos, P.J., van Rooijen, N., Rothwell, N.J. & Berkenbosch, F. (1993). Fever and thermogenesis in response to bacterial endotoxin involve macrophage-dependent mechanisms in rats. American Journal of Physiology 265, R1179-R1183.
11. Kluger, M.J. (1991). Fever: role of pyrogens and cryogens. Physiological Reviews 71, 93-127.
12. Saper, C.B. & Breder, C.D. (1992). Endogenous pyrogens in the CNS: role in the febrile response. Progress in Brain Research 93, 419-428
13. Moltz, H. (1993). Fever: causes and consequences. Neuroscience and Biobehavioral Reviews 17, 237-269.
14. Kluger, M.J., Kozak, W., Leon, L.R., Soszynski, D. & Conn, C.A. (1995). Cytokines and fever. Neuroimmunomodulation 2, 216-223.
15. Luheshi, G. & Rothwell, N. (1996). Cytokines and fever. International Archives of Allergy and Immunology 109, 301-307.
16. Luheshi, G.N. (1998). Cytokines and fever. Mechanisms and sites of action. Annals of the New York Academy of Sciences 856, 83-89.
17. Mackowiak, P.A. (1998). Concepts of fever. Archives of Internal Medicine 158, 1870-1881.
18. Zetterstrom, M., Sundgren-Andersson, A.K., Ostlund, P & Bartfai, T. (1998). Delineation of the proinflammatory cytokine cascade in fever induction. Annals of the New York Academy of Sciences 856, 48-52.
19. Dinarello, C.A. (1984). Interleukin-1. Reviews of Infectious Diseases 6, 51-95.
20. Endres, S., van der Meer, J.W. & Dinarello, C.A. (1987). Interleukin-1 in the pathogenesis of fever. European Journal of Clinical Investigation 17, 469-474.
21. Dinarello, C.A., Cannon, J.G., Mancilla, J., Bishai, I., Lees, J. & Coceani, F. (1991). Interleukin-6 as an endogenous pyrogen: induction of prostaglandin E2 in brain but not in peripheral blood mononuclear cells. Brain Research 562, 199-206.
22. Chai, Z., Gatti, S., Toniatti, C., Poli, V. & Bartfai, T. (1996). Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice. Journal of Experimental Medicine 183, 311-316.
23. Dinarello, C.A., Cannon, J.G., Wolff, S.M., Bernheim, H.A., Beutler, B., Cerami, A., Figari, I.S., Palladino M.A., Jr & O'Connor, J.V (1986). Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. Journal of Experimental Medicine 163, 1433-1450.
24. Kawasaki, H., Moriyama, M., Ohtani, Y., Naitoh, M., Tanaka, A. & Nariuchi, H. (1989). Analysis of endotoxin fever in rabbits by using a monoclonal antibody to tumor necrosis factor (cachectin). Infection and Immunity 57, 3131-3135.
25. Redford, J., Bishai, I. & Coceani, F. (1995). Pyrogen-prostaglandin coupling in the pathogenesis of fever: evidence against a role for nitric oxide. Canadian Journal of Physiology and Pharmacology 73, 1466-1474.
26. 2 receptor subtype EP1 antagonist may inhibit central interleukin-1β-induced fever in rats. American Journal of Physiology 275, R1762-R1765.
27. van Dijck, P. & van de Voorde, H. (1977). Factors affecting pyrogen testing in rabbits. Developments in Biological Standardisation 34, 57-63.
28. El-Khalik, A.F. & Benoliel, D.M. (1982). Effects of weight and sex of rabbits on the results of the testing of chorionic gonadotrophin injection according to the European Pharmacopoeia. The Journal of Pharmacy and Pharmacology 34, 209-210.
29. Greisman, S.E. & Hornick, R.B. (1969). Comparative pyrogenic reactivity of rabbit and man to bacterial endotoxin. Proceedings of the Society of Experimental Biology and Medicine 131, 1154-1158.
30. Bonenberger, J., Diekmann, W., Fennrich, S., Fischer, M., Friedrich, A., Hansper, M., Hartung, T., Jahnke, M., Löwer, J., Montag, T., Petri, E., Sonntag, H-G., Weigand, M., Wendel, A. & Zucker, B. (2000). Pyrogentestung mit Vollblut - Zusammenfassung eines Status-Workshops am PaulEhrlich-Institut, Langen, am 22.11.1999. Bundesgesundheitsblatt - Gesundheitsforschung -Gesundheitsschutz 7, 525-533.
31. Bellentani, L. (1982). Cyclic and chronobiological considerations when employing the rabbit fever test. Progress in Clinical and Biological Research 93, 329-342.
32. Hull, D., McIntyre, J. & Vinter, J. (1993). Age-related changes in endotoxin sensitivity and the febrile response of newborn rabbits. Biology of the Neonate 63, 370-379.
33. Cooper, J.F., Hochstein, H.D. & Seligmann Jr, E.B. (1972). The Limulus test for endotoxin (pyrogen) in radiopharmaceuticals and biologicals. Bulletin of the Parenteral Drug Association 26, 155-162.
34. Cooper, J.F. (1979). Acceptance of the Limulus test as an alternative pyrogen test for radiopharmaceutical and intrathecal drugs. Progress in Clinical and Biological Research 29, 345-352.
35. Cohen, Y., Bahri, F., Bruneau, J., Dubuis, M., Dubuis, N., Merlin, L., Michaud, T. & Peysson, S. (1986). Detection of endotoxins in radiopharmaceutical preparations. III. Limulus test assessment using radiopharmaceutical preparations; correlation with the rabbit pyrogen test. International Journal of Nuclear Medicine and Biology, Elmsford, NY 12, 477-481.
36. Booth, C. (1986). The Limulus amoebocyte lysate (LAL) assay: a replacement for the rabbit pyrogen test. Developments in Biological Standardisation 64, 271-275.
37. Flint, O. (1994). A timetable for replacing, reducing and refining animal use with the help of in vitro tests: the Limulus amebocyte lysate test (LAL) as an example. In Alternatives to Animal Testing: New Ways in the Biomedical Sciences, Trends and Progress (ed. C.A. Reinhardt), pp. 27-43. Weinheim, Germany: Verlag Chemie.
38. Liebsch, M. (1995). Die Geschichte der Validierung des LAL-Tests. ALTEX 12, 76-80.
39. Gardi, A. & Arpagaus, G.R. (1980). Improved microtechnique for endotoxin assay by the Limulus amebocyte lysate test. Analytical Biochem istiy 109, 382-385.
40. Friberger, P. (1985). The design of a reliable endotoxin test. Progress in Clinical and Biological Research 189, 139-149.
41. McCullough, K.Z. & Weidner-Loeven, C. (1992). Variability in the LAL test: comparison of three kinetic methods for the testing of pharmaceutical products. Journal of Parenteral Science and Technology 46, 69-72.
42. Meisel, J. (1995). Pyrogenbestimmung: Ein Vergleich verschiedener Methoden. ALTEX 12, 89-92.
43. Krüger, D. (1981). Der Pyrogennachweis mittels des Limulustests - Methoden, Ergebnisse, Möglichkeiten und Grenzen eines In-vitro-Tests. Die Pharmazeutische Industrie 43, 1-8
44. Pearson, F.C., Weary, M.E., Sargent, H.E., Novitsky, T.J., Lin, H., Lindsay, G., Berzofsky, R.N., Lane, A.L., Wilson, J.D., Cooper, J.F, Helme, E.J., Twohy, C.W., Basch, H.I., Rech, M., Slade, J.W & Winegar, M.P. (1985). Comparison of several control standard endotoxins to the National Reference Standard Endotoxin: an HIMA collaborative study. Applied Environmental Microbiology 50, 91-93.
45. Poole, S. & Mussett, M.V. (1989). The International Standard for Endotoxin: evaluation in an international collaborative study. Journal of Biological Standardisation 17, 161-171.
46. Poole, S., Dawson, P & Gaines Das, R.E. (1997). Second International Standard for Endotoxin: calibration in an international collaborative study. Journal of Endotoxin Research 4, 221-231.
47. Laude-Sharp, M., Haeffner-Cavaillon, N., Caroff, M., Lantreibecq, F., Pusineri, C. & Kazatchkine, M.D. (1990). Dissociation between the interleukin 1-inducing capacity and Limulus reactivity of lipopolysaccharides from Gram-negative bacteria. Cytokine 2, 253-258.
48. Fennrich, S., Fischer, M., Hartung, T., Lexa, P., Montag-Lessing, T., Sonntag, H-G., Weigandt, M. & Wendel, A. (1998). Entwicklung und Evaluierung eines Pyrogentests mit menschlichem Blut. ALTEX 15, 123-128.
49. Kundsin, R.B. & Walter, C.W. (1980). Detection of endotoxin on sterile catheters used for cardiac catheterization. Journal of Clinical Microbiology 11, 209-212.
50. Madison, V., Greve, T., Avery, B. & Wamberg, T. (1991). The effect of endotoxin-contaminated medium on in vitro fertilization and development of bovine oocytes matured in vitro. Reproduction Fertility and Development 31, 159-165.
51. Sobottka Ventura, A.C. & Bohnke, M. (1999). Bacterial lipopolysaccharides in sterile corneal organ-culture media. Cornea 18, 92-97.
52. Sarantila, R., Kotimaa, M., Kalliokoski, P. & Ponni, J. (1989). Endotoxin detection and quantification in airborne dust. Pharmeuropa 1, 20.
53. Taktak, Y.S., Selkirk, S., Bristow, A.F., Carpenter, A., Ball, C., Rafferty, B. & Poole, S. (1991). Assay of pyrogens by interleukin-6 release from monocytic cell lines. The Journal of Pharmacy and Pharmacology 43, 578.
54. Eperon, S. & Jungi, T.W. (1996). The use of human monocytoid lines as indicators of endotoxin. Journal of Immunological Methods 194, 121-129.
55. Eperon, S., DeGroote, D., Werner-Felmayer, G. & Jungi, T.W. (1997). Human monocytoid cell lines as indicators of endotoxin: comparison with rabbit pyrogen and Limulus amoebocyte lysate assay. Journal of Immunological Methods 207, 135-145.
56. Peterbauer, A., Werner, E.R. & Werner-Felmayer, G. (1999). Weiterentwicklung eines Zellkulturmodells zum Nachweis bakterieller Pyrogene. ALTEX 16, 3-8.
57. Peterbauer, A., Werner, E.R. & Werner-Felmayer, G. (1999). Neopterin and nitrite in supernatants from interferon-gamma-treated monocytoid cell lines: a tool to identify bacterial pyrogens. Pteridines 10, 112-118.
58. Peterbauer, A., Eperon, S., Jungi, T.W., Werner, E.R. & Werner-Felmayer, G. (2000). Interferon-gamma-primed monocytoid cell lines: optimizing their use for in vitro detection of bacterial pyrogens. Journal of Immunological Methods 233, 67-76.
59. Werner-Felmayer, G., Baier-Bitterlich, A.F., Fuchs, D., Hausen, A., Murr, C., Reibnegger, G., Werner, E.R. & Wachter, H. (1995). Detection of bacterial pyrogens on the basis of their effects on gamma interferon-mediated formation of neoplerin or nitrite in cultured monocyte cell lines. Clinical and Diagnostic Laboratory Immunology 2, 307-313.
60. Duff, G.W. & Atkins, E. (1982). The detection of endotoxin by in vitro production of endogenous pyrogen: comparison with Limulus amebocyte lysate gelation. Journal of Immunological Methods 52, 323-331.
61. Dinarello, C.A., O'Connor, J.V., LoPreste, G. & Swift, R.L. (1984). Human leukocytic pyrogen test for detection of pyrogenic material in growth hormone produced by recombinant Escherichia coli. Journal of Clinical Microbiology 20, 323-329.
62. Poole, S., Thorpe, R., Meager, A., Hubbard, A.R. & Gearing, A.J. (1988). Detection of pyrogen by cytokine release. Lancet 1, 130.
63. Poole, S., Thorpe, R., Meager, A. & Gearing, A.J. (1988). Assay of pyrogenic contamination in pharmaceuticals by cytokine release from monocytes. Developments in Biological Standardisation 69, 121-123.
64. Chia, J.K. & McManus, E.J. (1990). In vitro tumor necrosis factor induction assay for analysis of febrile toxicity associated with amphotericin B preparations. Antimicrobial Agents and Chemotherapy 34, 906-908.
65. Wind Hansen, E. & Dencker Christensen, J. (1990). Comparison of cultured human mononuclear cells, Limulus amebocyte lysate and rabbits in the detection of pyrogens. Journal of Clinical Pharmacology and Therapeutics 15, 425-433.
66. Morin, M., Schindler, R., Wakabayashi, G., Daumy, G., Dinarello, C.A. & Gelfand, J.A. (1991). Picogram concentrations of endotoxin stimulate synthesis of IL-1 beta and TNF alpha by human peripheral blood mononuclear cells exposed to recombinant human C5a. European Cytokine Network 2, 27-30.
67. Hartung, T & Wendel, A. (1995). Die Erfassung von Pyrogenen in einem humanen Vollblutmodell. ALTEX 12, 70-75.
68. Hartung, T. & Wendel, A. (1996). Eine Methode unter Verwendung von menschlichem Vollblut zum Ersatz des Pyrogentests am Kaninchen. In Forschung ohne Tierversuche (ed. H. Schöffl, H. Spielmann, H.A. Tritthart, K. Cussler, A.F. Goetschel, F.P Gruber & C.A. Reinhardt), pp. 34-39. Vienna, Austria: Springer-Verlag.
69. Hartung, T. & Wendel, A. (1996). Detection of pyrogens using human whole blood. In Vitro Toxicology 9, 353-359.
70. Pool, E.J., Johaar, G., James, S., Petersen, I. & Bouic, P. (1998). The detection of pyrogens in blood products using an ex vivo whole blood culture assay. Journal of Immunoassay 19, 95-111.
71. Fennrich, S., Berthold, S., Weigandt, M., Lexa, P., Sonntag, H-G., Hartung, T. & Wendel, A. (1999). Pyrogentestung mit humanem Blut. Der Tierschutzbeauftragte 2, 102-107.
72. Fennrich, S., Fischer, M., Hartung, T., Lexa, P., Montag-Lessing, T., Sonntag, H.G., Weigandt, M. & Wendel, A. (1999). Detection of endotoxins and other pyrogens using human whole blood. Developments in Biological Standardisation 101, 131-139.
73. Fennrich, S., Wendel, A. & Hartung, T. (1999). New applications of the human whole blood pyrogen assay (PyroCheck). ALTEX 16, 146-149.
74. Jahnke, M., Weigand, M. & Sonntag, H-G. (2000). Comparative testing for pyrogens in parenteral drugs using the human whole blood pyrogen test, the rabbit in vivo pyrogen test and the LAL test. European Journal of Parenteral Sciences 5, 39-44.
75. Hartung, T., Fennrich, S., Fischer, M., MontagLessing, T. & Wendel, A. (2000). Prevalidation of an alternative to the rabbit pyrogen test based on human whole blood. In Progress in the Reduction, Refinement and Replacement of Animal Experimentation (ed. M. Balls, A-M. van Zeller & M.E. Halder), pp. 991-999. Amsterdam, The Netherlands: Elsevier.
76. Murphy, P.A. (1991). Exogenous pyrogens. In Fever: Basic Mechanism and Management (ed. P Mackowiak), pp. 49-58. New York, USA: Raven Press.
77. Hitchcock, P.J. & Morrison, D.C. (1984). The protein components of bacterial endotoxins. In Chemistry of Endotoxin (ed. E.T. Rietschel), pp. 339-375. Amsterdam, The Netherlands: Elsevier.
78. Dinarello, C.A., Elin, R.J., Chedid, L. & Wolff, S.M. (1978). The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues. Journal of Infectious Diseases 138, 760-767.
79. Johannsen, L., Wecke, J., Obal, F., Jr & Krueger, J.M. (1991). Macrophages produce somnogenic and pyrogenic muramyl peptides during digestion of staphylococci. American Journal of Physiology 260, R126-R133.
80. Benz, R. (1988). Structure and function of porins from Gram-negative bacteria. Annual Review of Microbiology 42, 359-393.
81. Galdiero, F., Tufano, M.A., Galdiero, M., Masiello, S. & Di Rosa, M. (1990). Inflammatory effects of Salmonella typhimurium porins. Infection and Immunity 58, 3183-3186.
82. Galdiero, F., Sommese, L., Scarfogliero, P. & Galdiero, M. (1994). Biological activities: lethality, Schwartzman reaction and pyrogenicity of Salmonella typhimurium porins. Microbial Pathogenesis 16, 111-119.
83. Fumarola, D., Munno, I., Marcuccio, C. & Miragliotta, G. (1986). Endotoxin-like activity associated with Lyme disease Borrelia. Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene 263, 142-145.
84. Thomsen, A. & Loppnow, H. (1995). Cytokine production by mononuclear cells following Stimulation with a peptide-containing, endotoxin-free Escherichia coli extract. Arzneimittelforschung 45, 657-661.
85. Elm, R.J. & Utter, A.E. (1980). Positive Limulus amoebocyte lysate reactions with polyri boinosinic acid × polyribocytidylic acid. Journal of Clinical Microbiology 12, 502-505.
86. Won, S.J. & Lin, M.T. (1993). Endogenous pyrogen formation by human blood monocytes stimulated by polyriboinosinic acid × polyribocytidylic acid. Experientia 49, 157-159.
87. Cowdery, J.S., Chace, J.H., Yi, A.K. & Krieg, A.M. (1996). Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides. Journal of Immunology 156, 4570-4575.
88. Sparwasser, T., Miethke, T., Lipford, G., Borschert, K., Häcker, H., Heeg, K. & Wagner, H. (1997). Bacterial DNA causes septic shock. Nature, London 386, 336-337.
89. Wexler, H. & Oppenheim, J.D. (1979). Isolation, characterization, and biological properties of an endotoxin-like material from the Gram-positive organism Listeria monocytogenes. Infection and Immunity 23, 845-857.
90. Vallejo, J.G., Baker, C.J. & Edwards, M.S. (1996). Roles of the bacterial cell wall and capsule in induction of tumor necrosis factor alpha by type III group B streptococci. Infection and Immunity 64, 5042-5046.
91. Toien, O. & Mercer, J.B. (1996). Thermosensitivity is reduced during fever induced by Staphylococcus aureus cell walls in rabbits. Pflugers Archiv European Journal of Physiology 432, 66-74.
92. Huang, W.T., Lin, M.T. & Won, S.J. (1997). Staphylococcal enterotoxin A-induced fever is associated with increased circulating levels of cytokines in rabbits. Infection and Immunity 65. 2656-2662.
93. Huang, W.T., Lin, M.T. & Won, S.J. (1997). Mechanisms and sites of pyrogenic action exerted by staphylococcal enterotoxin A in rabbits. Neuroscience Letters 236, 53-56.
94. Roggiani, M., Stoehr, J.A., Leonard, B.A. & Schlievert, P.M. (1997). Analysis of toxicity of streptococcal pyrogenic exotoxin A mutants. Infection and Immunity 65, 2868-2875.
95. Hackett, S.E & Stevens, D.L. (1992). Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. The Journal of Infectious Diseases 165, 879-885.
96. Fitzgerald, D. & Pastan, I. (1993). Pseudomonas exotoxin and recombinant immunotoxins derived from it. Annals of the New York Academy of Sciences 685, 740-745.
97. Bhakdi, S., Grimminger, F., Suttorp, N., Walmrath, D. & Seeger, W. (1994). Proteinaceous bacterial toxins and pathogenesis of sepsis syndrome and septic shock: the unknown connection. Medical Microbiology and Immunology, Berlin 183, 119-144 [published erratum appears in Medical Microbiology and Immunology, Berlin 183, 343-344].
98. Houldsworth, S., Andrew, P.W. & Mitchell, T.J. (1994). Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes. Infection and Immunity 62, 1501-1503.
99. Murai, T., Nakagawa, Y. & Ogawa, Y. (1996). Potentiation of lethal endotoxin shock by streptococcal pyrogenic exotoxin in rabbits: possible relevance of hyperreactivity of macrophages to endotoxin. FEMS Immunology and Medical Microbiology 13, 269-272.
100. Carson, L.A., Bland, L.A., Cusick, L.B., Favero, M.S., Bolan, G.A., Reingold, A.L. & Good, R.C. (1988). Prevalence of nontuberculous mycobacteria in water supplies of hemodialysis centers. Applied Environmental Microbiology 54, 3122-3125.
101. Rawadi, G. & Roman-Roman, S. (1996). Mycoplasma membrane lipoproteins induced proinflammatory cytokines by a mechanism distinct from that of lipopolysaccharide. Infection and Immunity 64, 637.
102. Barwick, V.S., Wooten, M.H., Bradfield, J.F. & Myers, R.D. (1994). Fever of unknown origin: due to C. albicans or other fungi acting on the hypothalamus? Brain Research 635, 1-8.
103. Bate, C.A., Taverne, J. & Playfair, J.H. (1989). Soluble malarial antigens are toxic and induce the production of tumour necrosis factor in vivo. Immunology 66, 600-605.
104. Barry, D.W. Mayner, R.E., Hochstein, H.D., Dunlap, R.C., Rastogi, S.C., Hannah, J.E., Blackburn, R.J., Sullivan, J.L. & Gerety, R.J. (1976). Comparative trial of influenza vaccines. II. Adverse reactions in children and adults. American Journal of Epidemiology 104, 47-59.
105. Jakeman, K.J., Bird, C.R., Thorpe, R., Smith, H. & Sweet, C. (1991). Nature of the endogenous pyrogen (EP) induced by influenza viruses: lack of correlation between EP levels and content of the known pyrogenic cytokines, interleukin 1, interleukin 6 and tumour necrosis factor. Journal of General Virology 72, 705-709.
106. Gong, J.H., Sprenger, H., Hinder, F., Bender, A., Schmidt, A., Horch, S., Nain, M. & Gemsa, D. (1991). Influenza A virus infection of macrophages: enhanced tumor necrosis factor-alpha (TNF-alpha) gene expression and lipopolysaccharide-triggered TNF-alpha release. Journal of Immunology 147, 3507-3513.
107. Becker, S., Quay, J. & Soukup, J. (1991). Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. Journal of Immunology 147, 4307-4312.
108. Alluwaimi, A.M., Smith, H. & Sweet, C. (1994). Role of surface glycoproteins in influenza virus pyrogenicity. Journal of General Virology 75, 2835-2840.
109. Chang, D.M. & Shaio, M.F. (1994). Production of interleukin-1 (IL-1) and IL-1 inhibitor by human monocytes exposed to dengue virus. Journal of Infectious Diseases 170, 811-817.
110. Kurokawa, M., Imakita, M., Kumeda, C.A. & Shiraki, K. (1996). Cascade of fever production in mice infected with influenza virus. Journal of Medical Virology 50, 152-158.
111. Price, G.E., Fenton, R.J., Smith, H. & Sweet, C. (1997). Are known pyrogenic cytokines responsible for fever in influenza? Journal of Medical Virology 52, 336-340.
112. Soprana, E., Vigo, E., Verani, A., Blom, J., Siccardi, A.G., Vercelli, D. & Viale, G. (1994). Anti-idiotypic antibodies mimic molecular and functional properties of human IL-1 beta in vitro and in vivo. Lymphokine Cytokine Research 13, 325-330
113. Miller, K.M. & Anderson, J.M. (1988). Human monocyte/macrophage activation and interleukin 1 generation by biomedical polymers. Journal of Biomedical Material Research 22, 713-731.
114. Beloeil, J.C., Esnault, C., Fetizon, M. & Henry, R. (1980). Synthesis and pyrogenic effect of 3α, 7α-dihydroxy-5β-androstan-17-one and 3α-hydroxy-5β-androstane-7,17-dione. Steroids 35, 281-293.
115. Bodel, P. & Dillard, M. (1968). Studies on steroid fever. I. Production of leukocyte pyrogen in vitro by etiocholanolone. Journal of Clinical Investigation 47, 107-117.
116. Coleman, M.D. (1995). Dapsone toxicity: some current perspectives. General Pharmacology 26, 1461-1467.
117. Hollon, T. (2000). Researchers and regulators reflect on first gene therapy death. Nature Medicine 6, 6
118. Tsuchida, K., Takemoto, Y., Yamagami, S., Edney, H., Niwa, M., Tsuchiya, M., Kishimoto, T. & Shaldon, S. (1997). Detection of peptidoglycan and endotoxin in dialysate, using silkworm larvae plasma and Limulus amebocyte lysate methods. Nephron 75, 438-443.
119. Tsuchiya, M., Asahi, N., Suzuoki, E, Ashida, M. & Matsuura, S. (1996). Detection of peptidoglycan and beta-glucan with silkworm larvae plasma test. FEMS Immunological and Medical Microbiology 15, 129-134.
120. Szreder, Z. (1997). Do cardiovascular mechanisms participate in thermoregulatory activity of alpha 2-adrenoceptor agonists and antagonists in rabbits? Annals of the New York Academy of Sciences 813, 512-525.
121. Gagalo, I.T., Hac, E.E., Matuszek, M.T., Rekowski, P., Kupryszewski, G. & Korolkiewicz, K.Z. (1995). Thermoregulatory activity of sodium nitroprusside and arginine vasopressin. General Pharmacology 26, 393-397.
122. Gagalo, I.T., Hac, E.E., Korolkiewicz, K.Z., Matuszek, M.T. & Szreder, Z. (1996). Do sodium nitroprusside and L-NAME affect pyrogen fever in rabbits? Acta Physiologica Hungarica 84, 289-290.
123. 6-cyclohexyladenosine and 5′-(N-cyclopropyl)carboxamidoadenosine on pyrogen fever in rabbits. Annals of the New York Academy of Sciences 813, 353-359.
124. Bencsics, A., Elenkov, I.J. & Vizi, E.S. (1995). alpha 2-, alpha 2A-, alpha 2B/2C-Adrenoceptor subtype antagonists prevent lipopolysaccharide-induced fever response in rabbits. Brain Research 705, 302-306.
125. Flanigan, M.J., Accone, Q. & Laburn, H.P. (1992). Amitriptyline attenuates the febrile response to a pyrogen in rabbits. Journal of Basic Clinical Physiology and Pharmacology 3, 19-32.
126. Cradock, J.C., Vishnuvajjala, B.R., Chin, T.F., Hochstein, H.D. & Ackerman, S.K. (1986). Uridine-induced hyperthermia in the rabbit. Journal of Pharmacy and Pharmacology 38, 226-229.
127. Kleszynski, R.R., Hoffman, D., Odeneal, A. & Aldred, J.P. (1982). Apparent influence of adrenocorticotrophic hormone (ACTH) in the USP rabbit pyrogen test and evaluation of LAL as an alternative procedure. Progress in Clinical and Biological Research 93, 357-363.
128. Cooper, J.F., Weary, M.E. & Jordan, E.T. (1997). The impact of non-endotoxin LAL-reactive materials on Limulus amebocyte lysate analyses. PDA Journal of Pharmaceutical Science and Technology 51, 2-6.
129. Duner, K.I. (1995). The importance of the quality of water in Limulus amebocyte lysate tests. PDA Journal of Pharmaceutical Science and Technology 49, 119-121.
130. Hurley, J.C., Tosolini, F.A. & Louis, W.J. (1991). Quantitative Limulus lysate assay for endotoxin and the effect of plasma. Journal of Clinical Pathology 44, 849-854.
131. al-Khalifa, I.J., Naidu, N.V., Nallari, V.R. & Raut, H.I. (1989). Effect of some penicillins on the sensitivity of Limulus amoebocyte lysate test. Journal of Pharmacy and Pharmacology 41, 127-128.
132. Elin, R.J. & Wolff, S.M. (1973). Nonspecificity of the Limulus amebocyte lysate test: positive reactions with polynucleotides and proteins. Journal of Infectious Diseases 128, 349-352.
133. Ikemura, K., Ikegami, K., Shimazu, T., Yoshioka, T. & Sugimoto, T. (1989). False-positive result in Limulus test caused by Limulus amebocyte lysate-reactive material in immunoglobulin products. Journal of Clinical Microbiology 27, 1965-1968.
134. Roslansky, P.F., Dawson, M.E. & Novitsky, T.J. (1991). Plastics, endotoxins, and the Limulus amebocyte lysate test. Journal of Parenteral Science and Technology 45, 83-87.
135. Ross, V.C. & Bruch, C.W. (1982). Endotoxin testing of medical devices with LAL: FDA requirements. Progress in Clinical and Biological Research 93, 39-48.
136. Martinez, F. & Coleman, J.W. (1989). The effects of selected drugs, including chlorpromazine and non-steroidal anti-inflammatory agents, on polyclonal IgG synthesis and interleukin 1 production by human peripheral blood mononuclear cells in vitro. Clinical and Experimental Immunology 76, 252-257.
137. Council of Europe (1997). Parenteral Preparations. In European Pharmacopoeia, 3rd edn, pp. 1765-1767. Strasbourg, France: Council of Europe.
138. Becker, K.P., Ditter, B., Nimsky, C., Urbaschek, R. & Urbaschek, B. (1988). Endotoxin contents of phytopharmaceuticals: correlation with clinically observed side effects. Deutsche Medizinische Wochenschrift 113, 83-87.
139. Scheer, R. (1993). The effect of mistletoe lectins on the Limulus amebocyte lysate test. Arzneimittelforschung 43, 795-800.
140. Knight, P.A. & Lucken, R.N. (1977). Studies on the toxicity of a variety of human vaccines as measured by laboratory tests. Developments in Biological Standardisation 34, 181-187.
141. Tsai, C.M., Frasch, C.E., Rivera, E. & Hochstein, H.D. (1989). Measurements of lipopolysaccharide (endotoxin) in meningocoecal protein and polysaccharide preparations for vaccine usage. Journal of Biological Standardisation 17, 249-258.
142. Nyerges, G. & Jaszovszky, I. (1981). Reliability of the rabbit pyrogen test and of the Limulus test in predicting the pyrogenicity of vaccines in man. Acta Microbiologica Academiae Scientiarum Hungaricae 28, 235-243.
143. Montag, T., Lange, H., Schmidt, U., Strobel, J. & Exner, M. (1999). Bakterielle Kontamination von Blutkomponenten. Bundesgesundheitsblatt -Gesundheitsforschung - Gesundheitsschutz 42, 132-142.
144. Novitsky, T.J., Schmidt-Gengenbach, J. & Remillard, J.F. (1986). Factors affecting recovery of endotoxin adsorbed to container surfaces. Journal of Parenteral Science and Technology 40, 284-286.
145. Nelson, S.K., Knoernschild, K.L., Robinson, F.G. & Schuster, G.S. (1997). Lipopolysaccharide affinity for titanium implant biomaterials. Journal of Prosthetic Dentistry 77, 76-82.
146. Miller, A.J., Hopkins, S.J. & Luheshi, G.N. (1997). Sites of action of IL-1 in the development of fever and cytokine responses to tissue inflammation in the rat. British Journal of Pharmacology 120, 1274-1279.
147. Kirkpatrick, C.J., Wagner, M., Köhler, H., Bittinger, F., Otto, M. & Klein, C.L. (1997). The cell and molecular biological approach to biomaterial research: a perspective. Journal of Materials Science: Materials in Medicine 8, 131-141.
148. Kirkpatrick, C.J., Bittinger, F., Wagner, M., Köhler, H., van Kooten, T.G., Klein, C.L. & Otto, M. (1998). Current trends in biocompatibility testing. Proceedings of the Institution of Mechanical Engineers [H] 212, 75-84.
149. Deininger, C. (1998). Vorschlag eines Richtwertes für Endotoxin. Gefahrstoffe - Reinhaltung der Luft 1998, 23.
150. Senkpiel, K. (1999). Gesundheitliche Gefahren durch biogene Luftschadstoffe. Hygiene und Mikrobiologie 24, 45-49.
151. Descamps-Latscha, B., Herbelin, A., Nguyen, A.T., Uzan, M. & Zingraff, J. (1986). Haemodialysis-membrane-induced phagocyte oxidative metabolism activation and interleukin-1 production. Life Support Systems 4, 349-353.
152. Klein, E., Pass, T., Harding, G.B., Wright, R. & Million, C. (1990). Microbial and endotoxin contamination in water and dialysate in the central United States. Artificial Organs 14, 85-94.
153. Laude-Sharp, M., Caroff, M., Simard, L., Pusineri, C., Kazatchkine, M.D. & Haeffner-Cavaillon, N. (1990). Induction of IL-1 during hemodialysis: transmembrane passage of intact endotoxins (LPS). Kidney International 38, 1089-1094.
154. Darenkov, A.F., Yermolenko, V.M., Sinyukhin, VN., Stetsyuk, E.A., Kochlov, A.P. & Yarmolinski, J.S. (1991). Pathophysiological effects of a Limulus amoebocyte-lysate-positive substance during haemodialysis. Nephrology Dialysis Transplantation 3, 62-65.
155. Gordon, S.M., Oettinger, C.W., Bland, L.A., Oliver, J.C., Arduino, M.J., Aguero, S.M., McAllister, S.K., Favero, M.S. & Jarvis, W.R. (1992). Pyrogenic reactions in patients receiving conventional, high-efficiency, or high-flux hemodialysis treatments with bicarbonate dialysate containing high concentrations of bacteria and endotoxin. Journal of the American Society of Nephrology 2, 1436-1444.
156. Jackson, B.M., Beck-Sague, C.M., Bland, L.A., Arduino, M.J., Meyer, L. & Jarvis, W.R. (1994). Outbreak of pyrogenic reactions and Gram-negative bacteria in a hemodialysis center. American Journal of Nephrology 14, 85-89.
157. Dinarello, C.A. (1995). Interleukin-1 and interleukin-1 receptor antagonist production during haemodialysis: which cytokine is a surrogate marker for dialysis-related complications? Nephrology Dialysis Transplantation 10, 25-28.
158. Laurence, R.A. & Lapierre, S.T. (1995). Quality of hemodialysis water: a 7-year multicenter study. American Journal of Kidney Diseases 25, 738-750.
159. Arduino, M.J., Bland, L.A., McAllister, S.K. & Favero, M.S. (1995). The effects of endotoxin-contaminated dialysate and polysulfone or cellulosic membranes on the release of TNF alpha during simulated dialysis. Artificial Organs 19, 880-886.
160. Rudnick, J.R., Arduino, M.J., Bland, L.A., Cusick, L., McAllister, S.K., Aguero, S.M. & Jarvis, W.R. (1995). An outbreak of pyrogenic reactions in chronic hemodialysis patients associated with hemodialyzer reuse. Artificial Organs 19, 289-296.
161. Arvanitidou, M., Spaia, S., Katsinas, C., Pangidis, E, Constantinidis, T., Katsouyannopoulos, V. & Vayonas, G. (1998). Microbiological quality of water and dialysate in all haemodialysis centres of Greece. Nephrology Dialysis Transplantation 13, 949-954.
162. Martinez-Bermudez, A., Rodriguez-de Lecea, J., Soto-Esteras, T., Vazquez-Estevez, C. & Chena-Canete, C. (1991). Types of microbial contaminants in pharmaceutical raw materials. Revista Latinoamericana di Microbiologia 33, 153-157.
163. Majde, J.A. (1993). Microbial cell-wall contaminants in peptides: a potential source of physiological artifacts. Peptides 14, 629-632.
164. Donroe, A., Gabler, R., Winter, P., Christiansen, G., DeRosa, D., Hill, D., Hoggatt, E., Rea, J., Shannon, M. & Simons, I. (1990). Current practices in endotoxin and pyrogen testing in biotechnology. The Quality Assurance/Quality Control Task Group. Journal of Parenteral Science and Technology 44, 39-45
165. BPI (1999). Pharma Daten, pp. 52. Frankfurt, Germany: Bundesverband der Pharmazeutischen Industrie.
166. ICH (1995). Text on Validations of Analytical Procedures. CPMP/ICH/381/95. Geneva, Switzerland: International Conference on Harmonization.
167. Munson, T.E. (1982). FDA guideline for validation of the LAL test as an end-product endotoxin test for human and biological drugs. Progress in Clinical and Biological Research 93, 25-32.
168. Munson, T.E. (1987). FDA LAL guideline-update. Progress in Clinical and Biological Research 231, 143-147.
169. FDA (1991). US Food and Drug Administration Guideline on validation of the Limulus ameboeyte lysate test as an end-product endotoxin test for human and animal parenteral drugs, biological products and medical devices. DHHS, Dec. 1987 and Interim Guidance, 1991. Washington, DC, USA: DHHS.
170. Zarnow, K. & Spielman, H. (1998). Möglichkeiten zur Reduzierung oder zum Ersatz von Tierversuchen, die in DIN-Normen vorgeschrieben sind. ALTEX 15, 129-140.
171. Council of Europe (1997). 2.6.8. Pyrogens. In European Pharmacopoeia, 3rd edition, pp. 80-81. Strasbourg, France: Council of Europe.
172. Council of Europe (2001). 2.6.14. Bacterial Endotoxins. In European Pharmacopoeia, 3rd edition, Supplement, pp. 79-87. Strasbourg, France: Council of Europe.
173. Outschoorn, A.S. (1982). The USP bacterial endotoxins test. Progress in Clinical and Biological Research 93, 33-38.
174. USP (2000). Pyrogen Test. In The United States Pharmacopoeia 24, pp. 1850-1851. Rockville, MD, USA: US Pharmacopoeial Convention.
175. USP (2000). Bacterial Endotoxins Test. In The United States Pharmacopoeia 24, pp. 1829-1831. Rockville, MD, USA: US Pharmacopoeial Convention.
176. JP (2000). Bacterial Endotoxins Test. In The Japanese Pharmacopoeia 13, pp. 20-24. Shibuya, Shibuya-ku, Tokyo, Japan: The Society of Japanese Pharmacopoeia.
177. JP (1996). Pyrogen Test. In The Japanese Pharmacopoeia 13, pp. 61. Shibuya, Shibuya-ku, Tokyo, Japan: The Society of Japanese Pharmacopoeia.
178. Council of Europe (1994). Enquiry: monographs for antibiotics. PharmEuropa 6, 316.
179. Council of Europe (1998). Enquiry: monographs for biologicals. PharmEuropa 10, 692.
180. Balls, M. & Karcher, M. (1995). The validation of alternative test methods. ATLA 23, 884-886.
181. Balls, M., Blaauboer, B.J., Fentem, J.H., Bruner, L., Combes, R.D., Ekwall, B., Fielder, R.J., Guillouzo, A., Lewis, R.W., Lovell, D.P., Reinhardt, C.A., Repetto, G., Sladowski, D., Spielmann, H. & Zucco, F. (1995). Practical aspects of the validation of toxicity test procedures. The report and recommendations of ECVAM workshop 5. ATLA 23, 129-147.
182. Curren, R.D., Southee, J.A., Spielmann, H., Liebsch, M. & Fentem, J.H. (1995). The role of prevalidation in the development, validation and acceptance of alternative methods. ATLA 23, 211-217.
183. Fentem, J.H. & Balls, M. (1997). The ECVAM approach to validation. In Animal Alternatives, Welfare and Ethics (ed. L.F.M. van Zutphen & M. Balls), pp. 1083-1089. Amsterdam, The Netherlands: Elsevier.
184. Balls, M. & Fentem, J.H. (1997). Progress toward the validation of alternative test. ATLA 25, 33-43.
185. Cooper-Hannan, R., Harbell, J.W., Coecke, S., Balls, M., Bowe, G., Cervinka, M., Clothier, R., Hermann, F, Klahm, L.K., de Lange, J., Liebsch, M. & Vanparys, P. (1999). The principles of Good Laboratory Practice: application to in vitro toxicology studies. The report and recommendations of ECVAM workshop 37. ATLA 27, 539-577.
186. ECVAM (1998). Statement on the scientific validity of the 3T3 NRU PT test (an in vitro test for phototoxic potential). ATLA 26, 7-8.
187. ECVAM (1998). Statement on the application of the 3T3 NRU PT test to UV filter chemicals. ATLA 26, 385-386.
188. ECVAM (1998). Statement on the scientific validity of the rat skin transcutaneous electrical resistence (TER) test (an in vitro test for skin corrosivity). ATLA 26, 275-278.
189. ™ test (an in vitro test for skin corrosivity). ATLA 26, 278-280.
190. ECVAM (1998). Statement on the scientific acceptability and practical availability of in vitro methods for the production of monoclonal antibodies. ATLA 26, 383-385.